US drug approvals
6 approvals with a product on the US market
- Zurnai (Autoinjector) NDA218590 · approved 7 Aug 2024
- Nalmefene Hydrochloride ANDA212955 · approved 8 Feb 2022
- Hysingla Er NDA206627 · approved 20 Nov 2014
- Butrans NDA021306 · approved 30 Jun 2010
- Oxycontin NDA022272 · approved 5 Apr 2010
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.